Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic

View ORCID ProfileGanna Rozhnova, View ORCID ProfileChristiaan H. van Dorp, View ORCID ProfilePatricia Bruijning-Verhagen, View ORCID ProfileMartin C.J. Bootsma, View ORCID ProfileJanneke H.H.M. van de Wijgert, View ORCID ProfileMarc J.M. Bonten, View ORCID ProfileMirjam E. Kretzschmar
doi: https://doi.org/10.1101/2020.12.07.20245506
Ganna Rozhnova
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
2BioISI—Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ganna Rozhnova
  • For correspondence: g.rozhnova@umcutrecht.nl
Christiaan H. van Dorp
3Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christiaan H. van Dorp
Patricia Bruijning-Verhagen
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricia Bruijning-Verhagen
Martin C.J. Bootsma
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
4Mathematical Institute, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin C.J. Bootsma
Janneke H.H.M. van de Wijgert
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
5The Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janneke H.H.M. van de Wijgert
Marc J.M. Bonten
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
6Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc J.M. Bonten
Mirjam E. Kretzschmar
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mirjam E. Kretzschmar
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In autumn 2020, many countries, including the Netherlands, are experiencing a second wave of the COVID-19 pandemic. Health policymakers are struggling with choosing the right mix of measures to keep the COVID-19 case numbers under control, but still allow a minimum of social and economic activity. The priority to keep schools open is high, but the role of school-based contacts in the epidemiology of SARS-CoV-2 is incompletely understood. We used a transmission model to estimate the impact of school contacts on transmission of SARS-CoV-2 and to assess the effects of school-based measures, including school closure, on controlling the pandemic at different time points during the pandemic.

Methods and Findings The age-structured model was fitted to age-specific seroprevalence and hospital admission data from the Netherlands during spring 2020. Compared to adults older than 60 years, the estimated susceptibility was 23% (95%CrI 20—28%) for children aged 0 to 20 years and 61% (95%CrI 50%—72%) for the age group of 20 to 60 years. The time points considered in the analyses were (i) August 2020 when the effective reproduction number (Re) was estimated to be 1.31 (95%CrI 1.15—2.07), schools just opened after the summer holidays and measures were reinforced with the aim to reduce Re to a value below 1, and (ii) November 2020 when measures had reduced Re to 1.00 (95%CrI 0.94—1.33). In this period schools remained open. Our model predicts that keeping schools closed after the summer holidays, in the absence of other measures, would have reduced Re by 10% (from 1.31 to 1.18 (95%CrI 1.04—1.83)) and thus would not have prevented the second wave in autumn 2020. Reducing non-school-based contacts in August 2020 to the level observed during the first wave of the pandemic would have reduced Re to 0.83 (95%CrI 0.75—1.10). Yet, this reduction was not achieved and the observed Re in November was 1.00. Our model predicts that closing schools in November 2020 could reduce Re from the observed value of 1.00 to 0.84 (95%CrI 0.81—0.90), with unchanged non-school based contacts. Reductions in Re due to closing schools in November 2020 were 8% for 10 to 20 years old children, 5% for 5 to 10 years old children and negligible for 0 to 5 years old children.

Conclusions The impact of measures reducing school-based contacts, including school closure, depends on the remaining opportunities to reduce non-school-based contacts. If opportunities to reduce Re with non-school-based measures are exhausted or undesired and Re is still close to 1, the additional benefit of school-based measures may be considerable, particularly among the older school children.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is a modelling study

Funding Statement

The contribution of CHvD was under the auspices of the US Department of Energy (contract number 89233218CNA000001) and supported by the National Institutes of Health (grant number R01-OD011095). MEK was supported by ZonMw grant number 10430022010001, ZonMw grant number 91216062, and H2020 project 101003480 (CORESMA). MJMB and PBV were supported by H2020 project 101003589 (RECOVER). GR was supported by FCT project 131_596787873. We thank Michiel van Boven from the National Institute of Public Health and the Environment, Bilthoven, The Netherlands, for valuable discussions and continuing advice during the course of this project. We thank Mui Pham and Alexandra Teslya for comments on the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a modeling study which did not require IRB and/or ethics committee approvals.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data, the R, Stan and Mathematica codes reproducing this study are available at https://github.com/lynxgav/COVID19-schools

https://github.com/lynxgav/COVID19-schools

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
Ganna Rozhnova, Christiaan H. van Dorp, Patricia Bruijning-Verhagen, Martin C.J. Bootsma, Janneke H.H.M. van de Wijgert, Marc J.M. Bonten, Mirjam E. Kretzschmar
medRxiv 2020.12.07.20245506; doi: https://doi.org/10.1101/2020.12.07.20245506
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
Ganna Rozhnova, Christiaan H. van Dorp, Patricia Bruijning-Verhagen, Martin C.J. Bootsma, Janneke H.H.M. van de Wijgert, Marc J.M. Bonten, Mirjam E. Kretzschmar
medRxiv 2020.12.07.20245506; doi: https://doi.org/10.1101/2020.12.07.20245506

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)